Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

TRVI holding history

Trevi Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRVI overviewAll 13F holders of TRVIFull Q4 2025 holdings

Shares (Q4 2025)
6,434,655
Value
$80.6M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of TRVI by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20256,434,655$80.6M<0.1%+607,669+10.4%AddedHolders
Q3 20255,826,986$53.3M<0.1%+510,295+9.6%AddedHolders
Q2 20255,316,691$29.1M<0.1%+1,478,659+38.5%AddedHolders
Q1 20253,838,032$24.1M<0.1%+328,819+9.4%AddedHolders
Q4 20243,509,213$14.5M<0.1%+246,832+7.6%AddedHolders
Q3 20243,262,381$10.9M<0.1%+824,930+33.8%AddedHolders
Q2 20242,437,451$7.26M<0.1%+133,803+5.8%AddedHolders
Q1 20242,303,648$7.95M<0.1%+60,249+2.7%AddedHolders
Q4 20232,243,399$3.01M<0.1%+285,524+14.6%AddedHolders
Q3 20231,957,875$4.27M<0.1%+44,613+2.3%AddedHolders
Q2 20231,913,262$4.57M<0.1%+413,511+27.6%AddedHolders
Q1 20231,499,751$2.77M<0.1%+60,158+4.2%AddedHolders
Q4 20221,439,593$2.78M<0.1%+115,216+8.7%AddedHolders
Q3 20221,324,377$2.04M<0.1%+1,087,437+459.0%AddedHolders
Q2 2022236,940$666.0K<0.1%+84,109+55.0%AddedHolders
Q1 2022152,831$336.0K<0.1%+10,780+7.6%AddedHolders
Q4 2021142,051$111.0K<0.1%+5,502+4.0%AddedHolders
Q3 2021136,549$192.0K<0.1%+3,334+2.5%AddedHolders
Q2 2021133,215$300.0K<0.1%00.0%UnchangedHolders
Q1 2021133,215$361.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.